Autopsy report · NCT02790736

Brief Intervention to Reduce Fear of Public Speaking

“COVID-19 restrictions”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 4 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

New York State Psychiatric Institute

Sponsor type

University, hospital or other

Conditions

Social Anxiety Disorder

Interventions

propranolol; Placebo

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Bulimia and Anorexia Nervosa
  “COVID-19 pandemic restrictions.” (92% match in meaning)
• RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches
  “Covid restrictions” (91% match in meaning)
• Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)
  “COVID-19 Research Restrictions” (87% match in meaning)
• Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.
  “Health restrictions due to the COVID-19 pandemic” (84% match in meaning)
• Evaluation of Surgery in Elderly With Traumatic Acute SubDural Hematoma
  “Lack of inclusion / COVID-19 regulations” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.